StreetInsider.com News Articles

Ashland to host Innovation Day for analysts and investors

Mon, 31 Aug 2026 18:30:00 -0400

Wilmington, Del., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) will host a live Innovation Day webcast for analysts and investors from Wilmington, Delaware on September 17, 2026. The event will provide an updated view of Ashland’s Technology Platforms, including their commercial progress and scalability. Registration is required and can be accessed from the following link: innovationday26.ashland.com

Participants will hear from Ashland executives and senior technology leaders as they provide an in-depth review of the latest innovations and expanding commercial opportunities. The presentations will detail how these advancements are poised to impact

Ashland to host Innovation Day for analysts and investors

Mon, 31 Aug 2026 18:30:00 -0400

Ashland to host Innovation Day for analysts and investors

Mon, 31 Aug 2026 18:30:00 -0400

Ashland to host Innovation Day for analysts and investors

Mon, 31 Aug 2026 18:30:00 -0400

Ashland to host Innovation Day for analysts and investors

Mon, 31 Aug 2026 18:30:00 -0400

Ashland to host Innovation Day for analysts and investors

Mon, 31 Aug 2026 18:30:00 -0400

Ashland launches permexa sodium caprate for oral drug delivery

Mon, 24 Aug 2026 07:03:32 -0400

Ashland Inc. (NYSE: ASH) has launched permexa™ sodium caprate, a pharmaceutical excipient designed to support the development and manufacturing of oral peptide and biologic drug products, including GLP-1 agonists, according to a company statement.

The product is an intestinal permeation enhancer built on sodium caprate chemistry and manufactured through an IP-protected process. Ashland says the excipient is engineered to offer improved powder flow, enhanced compressibility and greater formulation consistency compared to conventional sodium caprate, while preserving permeability enhancement properties needed for oral drug delivery.

Ahead of the commercial launch, Ashland reported engagement with pharmaceutical companies, biotechs and contract development and manufacturing organizations

Ashland advances high-growth oral biologics delivery applications with launch of permexa™ sodium caprate

Mon, 24 Aug 2026 07:00:00 -0400

Commercialization follows strong interest from pharmaceutical developers worldwide

WILMINGTON, Del., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH), is announcing the launch of permexa™ sodium caprate, a high-performance intestinal permeation enhancer designed to support the scalable development and commercialization of oral peptide, biologic and low-permeability drug products, including rapidly expanding GLP-1 agonists and related therapeutic pipelines.

The launch comes at a time of significant market momentum in oral peptide and biologics development. Pharmaceutical companies continue to invest heavily in oral alternatives to injectable therapies, driven by the potential to improve patient convenience, enhance treatment adherence

Ashland advances high-growth oral biologics delivery applications with launch of permexa™ sodium caprate

Mon, 24 Aug 2026 07:00:00 -0400

Commercialization follows strong interest from pharmaceutical developers worldwide

Ashland advances high-growth oral biologics delivery applications with launch of permexa™ sodium caprate

Mon, 24 Aug 2026 07:00:00 -0400

Commercialization follows strong interest from pharmaceutical developers worldwide

Ashland advances high-growth oral biologics delivery applications with launch of permexa™ sodium caprate

Mon, 24 Aug 2026 07:00:00 -0400

Commercialization follows strong interest from pharmaceutical developers worldwide

Form SCHEDULE 13G/A ASHLAND INC. Filed by: MASSACHUSETTS FINANCIAL SERVICES CO /MA/

Wed, 12 Aug 2026 17:01:00 -0400

si-local-file:///var/storage/secattach/20260812/26914057.html

Form SCHEDULE 13G/A ASHLAND INC. Filed by: MASSACHUSETTS FINANCIAL SERVICES CO /MA/

Wed, 12 Aug 2026 17:01:00 -0400

si-local-file:///var/storage/secattach/20260812/26914057.html

Form 4 ASHLAND INC. For: Aug 11 Filed by: LAMPKIN ROBIN E.

Wed, 12 Aug 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260812/26913439.html

Form 4 ASHLAND INC. For: Aug 11 Filed by: LAMPKIN ROBIN E.

Wed, 12 Aug 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260812/26913439.html

Form 8-K/A ASHLAND INC. For: Jul 27

Mon, 10 Aug 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260810/26898497.html

Form 8-K/A ASHLAND INC. For: Jul 27

Mon, 10 Aug 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260810/26898497.html

Ashland (ASH) Declares $0.42 Quarterly Dividend; 2.2% Yield

Fri, 07 Aug 2026 17:02:45 -0400

Ashland (NYSE: ASH) declared a quarterly dividend of $0.42 per share, or $1.68 annualized.

The dividend will be payable on September 15, 2026, to stockholders of record on September 1, 2026, with an ex-dividend date of August 31, 2026.

The annual yield on the dividend is 2.2 percent.

For a dividend history and other dividend-related data on Ashland (ASH) click here.

Ashland board authorizes quarterly dividend

Fri, 07 Aug 2026 17:00:00 -0400

WILMINGTON, Del., Aug. 07, 2026 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.42 cents per share on the company's common stock. The dividend will be payable on September 15, 2026, to stockholders of record at the close of business on September 1, 2026.

As of July 31, 2026, there were 45,805,711 shares of Ashland common stock outstanding.

About Ashland
Ashland Inc. (NYSE: ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environmental, social and governance (ESG).

Ashland board authorizes quarterly dividend

Fri, 07 Aug 2026 17:00:00 -0400

As of July 31, 2026, there were 45,805,711 shares of Ashland common stock outstanding.

About Ashland
Ashland Inc. (NYSE: ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environmental, social and governance (ESG).

Ashland board authorizes quarterly dividend

Fri, 07 Aug 2026 17:00:00 -0400

As of July 31, 2026, there were 45,805,711 shares of Ashland common stock outstanding.

About Ashland
Ashland Inc. (NYSE: ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environmental, social and governance (ESG).

Ashland board authorizes quarterly dividend

Fri, 07 Aug 2026 17:00:00 -0400

As of July 31, 2026, there were 45,805,711 shares of Ashland common stock outstanding.

About Ashland
Ashland Inc. (NYSE: ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environmental, social and governance (ESG).

Ashland said to explore sale amid takeover interest - Bloomberg

Fri, 07 Aug 2026 15:59:53 -0400

(Updated - August 7, 2026 3:59 PM EDT)

Ashland Inc. is reportedly exploring a potential sale after receiving takeover interest from multiple suitors, according to people familiar with the matter cited by Bloomberg.

The specialty chemicals company is working with Citigroup Inc. and Lazard Inc. as financial advisers as it engages with both strategic and financial buyers, according to the sources, who asked not to be identified because the information is not public.

Private equity firms including Advent, Apollo Global Management Inc. and Carlyle Group Inc. are among those that have had contact with Ashland, which makes additives and specialty ingredients used in

Ashland said to explore sale amid takeover interest - Bloomberg

Fri, 07 Aug 2026 15:59:53 -0400

(Updated - August 7, 2026 3:59 PM EDT)

Ashland Inc. is reportedly exploring a potential sale after receiving takeover interest from multiple suitors, according to people familiar with the matter cited by Bloomberg.

Private equity firms including Advent, Apollo Global Management Inc. and Carlyle Group Inc. are among those that have had contact with Ashland, which makes additives and specialty ingredients used in

Ashland said to explore sale amid takeover interest - Bloomberg

Fri, 07 Aug 2026 15:59:53 -0400

(Updated - August 7, 2026 3:59 PM EDT)

Ashland Inc. is reportedly exploring a potential sale after receiving takeover interest from multiple suitors, according to people familiar with the matter cited by Bloomberg.

Private equity firms including Advent, Apollo Global Management Inc. and Carlyle Group Inc. are among those that have had contact with Ashland, which makes additives and specialty ingredients used in